Loading...

KPTI KARYOPHARM THERAPEUTICS INC Capital Structure Changes 8-K Filing

KRYP

KPT

KARYOPHARM THERAPEUTICS INC

(KPTI)

2026 8-K

Securities Placement

Stock Purchase Agreement

Credit Agreement Update

Share Increase Approval

Financial Results Announced

Financial Update

Earnings Announcement

Financial Transactions

Financial Restructuring

Board Resignation

Potential Financing Transac...

Equity Offerings

Financial Statements

Financial Results

Executive Compensation

Shareholder Approvals

Management Change

Regulatory Update

Management Change

Lease Amendment

Financial Results

Clinical Trial Update

Nasdaq Compliance Notice

Annual Meeting Approval

Exchange of Convertible Sen...

Debt Restructuring, Convert...

Financial Results Announcement

Compliance Regained

Earnings Reports

Resignation of Director

Financial Results Announcement

Appointment of Independent ...

Annual Meeting Results

Financial Results Announcement

Regulation FD Disclosure

Equity Awards Approval

Earnings Report

External Links:

On February 27, 2026, Karyopharm Therapeutics entered a Second Amendment to reduce capital requirements, allowing deferred payments until September 2026, contingent on raising at least $25 million by June 10, 2026.

AI Assistant

KARYOPHARM THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.